Maxwell Skor

Stock Analyst at Morgan Stanley

(n/a)

# 4,673

Out of 4,876 analysts

3

Total ratings

n/a

Success rate

-32.89%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Maxwell Skor

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TCRX TScan Therapeutics	Assumes: Overweight	$10	$1.50	+566.67%	1	Mar 14, 2025
	IVVD Invivyd	Maintains: Overweight	$9.5 → $3.55	$0.79	+350.22%	2	Nov 20, 2024

TScan Therapeutics

Mar 14, 2025

Assumes: Overweight

Price Target: $10

Current: $1.50

Upside: +566.67%

Invivyd

Nov 20, 2024

Maintains: Overweight

Price Target: $9.5 → $3.55

Current: $0.79

Upside: +350.22%